Next Article in Journal
Semisynthesis of 6β-Acetoxyvouacapane Derivatives via the Ugi-Azide Multicomponent Reaction
Previous Article in Journal
Expression of β-Catenin Marker in Colorectal Cancer Cells after Treatment with Royal Jelly
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Chemistry Proceedings
Volume 12
Issue 1
10.3390/ecsoc-26-13641
chemproc-logo
Submit to this Journal
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Aromatic Iodides: Synthesis and Conversion to Heterocycles †

by
Florence Mongin
*,
William Erb
and
Frédéric Lassagne
Univ Rennes, CNRS, ISCR (Institut des Sciences Chimiques de Rennes)—UMR 6226, F-35000 Rennes, France
*
Author to whom correspondence should be addressed.
†
Presented at the 26th International Electronic Conference on Synthetic Organic Chemistry, 15–30 November 2022; Available online: https://ecsoc-26.sciforum.net.
Chem. Proc. 2022, 12(1), 20; https://doi.org/10.3390/ecsoc-26-13641
Published: 16 November 2022
(This article belongs to the Proceedings of The 26th International Electronic Conference on Synthetic Organic Chemistry)
Browse Figures
Versions Notes

Abstract

:
Aromatic heterocycles can be found in many molecules endowed with specific properties, in particular for applications in the fields of medicinal chemistry and materials science. In this group, we notably develop synthetic methodologies to selectively introduce iodine onto aromatic compounds and to use this heavy halogen in order to build heterocycles of interest. While we sometimes employed direct iodinations on electron-enriched aromatic compounds, we mainly optimized deprotometallation–iodolysis sequences to functionalize substrates sensitive to nucleophilic attacks. In particular, hindered lithium amide–metal trap tandems have been designed to overcome the low tolerance of some functional groups (e.g., ketones or sensitive diazines) toward organolithiums. The aromatic iodides generated in these ways have been involved in transition metal–catalyzed cross-couplings to access original scaffolds (oxazoloquinoxalines, pyrazinoisatins, pyrazinocarbazoles, etc.). We specifically developed the use of aromatic iodides in the copper-mediated N-arylation of anilines, e.g., to reach triarylamines. Combined with subsequent cyclizations, these reactions allowed access to numerous heterocyclic compounds (such as acridones, acridines, other aza-aromatic polycycles and helicene-like structures) with potential applications. From some of the scaffolds obtained, biological evaluation in the frame of collaborations allowed properties of interest to be discovered (e.g., specific inhibition of protein kinases GSK-3 or PIM, related to cancer development).

1. Introduction

Aromatic iodides are particularly useful substrates for a wide range of reactions, including cross-coupling reactions catalyzed by transition metals.
In this mini-review, our goal is to highlight the contributions of our group in this field, whether to rationalize the regioselectivity of direct iodination reactions, to implement deprotometallation–iodolysis sequences from sensitive aromatic compounds in order to reach other iodinated derivatives, and finally to use these iodinated derivatives as partners in the N-arylation of anilines.
Whenever possible, we have sought to show the usefulness of the synthesized iodinated derivatives as well as the compounds obtained by N-arylation. Thus, the potential applications of the synthesized molecules, especially their biological activity, have been discussed.

2. Selective Introduction of Iodine onto Aromatic Compounds

In this paragraph, we will present, through selected examples, the two ways that we have considered to introduce an iodine on aromatic compounds: direct iodination and deprotometalation followed by iodolysis.

2.1. Direct Iodination and Application to the Synthesis of Heterocycles of Interest

Direct iodination generally concerns electron-rich aromatic compounds, and the reaction often takes place at the carbon site that possesses the most negative atomic carbon charge. Another way to predict the outcome of aromatic electrophilic substitution (SEAr) reactions [1], such as iodination, relies on Fukui’s concept (in a reaction with an electrophile, an aromatic compound reacts at its carbon with the highest amplitudes of the highest occupied molecular orbital (HOMO) coefficient—in absolute value) [2]. For example, calculating the amplitudes of these coefficients for 1-(3,5-dimethylphenyl)-7-azaindole and 1-(2-thienyl)-7-azaindole by applying Hückel’s theory [3,4] indicates a favored reaction at C3 and C5′, respectively, in accordance with the experimental results [5] (products 1 and 2; Figure 1).
From various 6-aminoquinoxalines [6], iodination similarly occurred at C5, as predicted by the amplitudes of the HOMO coefficients (see examples in Figure 2). The 6-amino-5-iodoquinoxalines 3–5 thus obtained in high yields are particularly interesting substrates for subsequent functionalization. Indeed, inspired by Verma and co-workers [7], a derivative of 3 was converted into the corresponding 6-thioureido derivative by reaction with benzoyl isothiocyanate (Scheme 1, top). Subsequent cyclization led to an original thiazolo[5,4-f]quinoxaline (Scheme 1, right) that was identified as a selective CK1 kinase inhibitor and showed a promising antiproliferative activity on melanoma cells (66% inhibition at 10 μM). From the same derivative of 3, reaction with phenylacetylene and sulfur under the conditions of Wu and Jiang (tripotassium phosphate, and catalytic copper(I) iodide and 1,10-phenanthroline, in hot dimethylsulfoxide (DMSO) under oxygen) [8] led to another original member of the thiazolo[5,4-f]quinoxaline family [9] (Scheme 1, bottom left).
To access oxazolo[5,4-f]quinoxalines, which were at that time unknown heterocycles of interest [10], 6-amino-5-iodoquinoxaline 3 was first converted to carboxamides (here, N-aroylation with nicotinoyl chloride; Scheme 2, top left). After substitution of the chlorine atom by a secondary amine, the oxazole ring was finally built by using a copper-catalyzed cyclization [11] (potassium carbonate, and catalytic copper(I) iodide in DMSO at 110 °C). The synthesized compounds were tested on a panel of disease-related protein kinases, and some of these proved to be strong, ATP-competitive inhibitors of GSK3, with a preference for the isoform α [12] (Scheme 2, right).
An access to new pyrazino[b,e]isatins was developed in parallel with the 6-aminoquinoxalines 4 and 5. After introduction of the required two carbons by a Sonogashira coupling with trimethylsilylacetylene [13], under conditions already reported (diisopropylamine, and catalytic palladium(II) chloride bis(triphenylphosphine) and copper(I) iodide in tetrahydrofuran (THF) at room temperature) [14], the alkynes were hydrated toward the 5-acetyl-6-amino derivatives (Scheme 3, left). The original pyrazino-fused isatins were finally formed by oxidative cyclization in the presence of selenium oxide (Scheme 3, right). When tested on melanoma cells, the dimethoxylated derivative exhibited significant activity (41% inhibition at 10 μM) [9].

2.2. Deprotometalation with In Situ Trapping–Iodolysis as an Alternative to Direct Iodination

Deprotolithiation followed by electrophilic trapping is an elegant way to functionalize aromatic compounds for which direct iodination is ineffective, either because it does not work or because it does not achieve the desired regioselectivity [15,16,17,18,19,20]. However, due to the high ionic character of the carbon–metal bond, sensitive aromatic substrates (e.g., heterocycles) and aryllithiums of low stability might not be tolerated. In this case, alternative approaches such as the use of lithium -ate bases (e.g., lithium zincates) and Turbo bases (e.g., LiCl-containing zinc amides) prepared from hindered secondary amines such as 2,2,6,6-tetramethylpiperidine (H-TMP) have been developed [21,22,23,24,25,26].
A complementary approach consists of carrying out the deprotolithiation in the presence of an electrophilic trap capable of intercepting the aryllithium as soon as it is generated, thus avoiding side reactions. This was made possible by using the lithium amides LiDA (lithium diisopropylamide) and LiTMP (lithium 2,2,6,6-tetramethylpiperidide) as bases, and chlorotrimethylsilane and triisopropyl borate as electrophiles. Moreover, for reversible reactions that do not benefit from the difference of four pKa units between the base and the substrate, in situ trapping is a way to push the reaction to completion [27]. This strategy was developed in the 1980s by using silicon-based and boron-based electrophiles, and more recently by using metal-based in situ traps [28].
In our group, we have been especially interested in the use of ZnCl2∙TMEDA (TMEDA = N,N,N’,N’-tetramethylethylenediamine) as an in situ trap to intercept aryllithiums that could otherwise either attack the aromatic substrate or undergo degradation. The thus generated arylzinc compounds can then be easily converted to the corresponding iodides [28]. This was, for example, performed on 2,3-diphenylquinoxaline, affording the iodide 6 in good yield [29] (Scheme 4). A similar approach was successfully applied to pyrido[2,3-b]pyrazine for which the lithiated derivative has a low stability. The iodide 7 thus obtained was next involved in a palladium-catalyzed N-arylation/C-H activation sequence with 2-chloroaniline. Under conditions inspired by those of Maes [30] and Pieters et al. [31] for related reactions (diazabicyclo[5.4.0]undec-7-ene, and catalytic dipalladium(0) tris(dibenzylideneacetone) and Xantphos, in dioxane), using a high 180 °C temperature for 10 min under microwave irradiation led to an original heterocycle in 70% yield [29] (Scheme 5).
Due to their low LUMO levels, pyrazines are prone to nucleophilic attacks [32,33,34]. From 2-phenyloxazolo[4,5-b]pyrazine, the use of LiTMP in the presence of ZnCl2∙TMEDA (in order to intercept the formed aryllithium before competitive reactions) allowed a chemoselective reaction to take place. However, due to the small reactivity difference between the two positions next to the pyrazine nitrogens, two iodides 8 and 8′ were formed. However, by repeating the reaction, it proved possible to prepare diiodide 9, from which a double Suzuki coupling was achieved using 2-thienylboronic acid [35] (Scheme 6).
Due to our interest in the synthesis of diarylketones by deprotocupration using TMP-based lithium cuprates [26], we were eager to functionalize such compounds by using the tandem reagents LiTMP and ZnCl2∙TMEDA. The protocol was successfully applied to 3-aroylpyridines, but required low temperatures given the sensitivity of these substrates to nucleophiles. It was observed that the presence of a heteroatom-containing substituent at the 2-position of the pyridine ring favored the reaction, allowing the iodides 10 to be obtained in higher yields [36] (Scheme 7).
Pleasingly, this functionalization was not limited to pyridine ketones as the iodides 11a–d were also provided from (thio)xanthones and nitrogen analogs. In the particular case of 2-benzoylthiophene, the reaction did not take place next to the carbonyl group, but this time next to the sulfur (product 11e; Scheme 8a). From fluorenone, the reaction proved to be less efficient (52% yield for product 11f) than from xanthone due to a competitive addition of the lithiated intermediate on the carbonyl function of the substrate (11′f isolated in 35% yield) before interception by ZnCl2∙TMEDA. This could be due either to a reduced stabilization of the lithiated intermediate or to a greater sensitivity of the fluorenone ketone function. The presence of a nitrogen at the 4-position of the fluorenone made the reaction more complex (only 33% yield of product 11g), this was demonstrated by the presence of a second remote deprotometalation that was also observed (11′g obtained in 20% yield) [36,37] (Scheme 8b).
This approach is of particular interest as aromatic ketones bearing an iodine next to the carbonyl group are key intermediates to access larger heterocycles. For example, reacting 1-iodothioxanthone (11b) with guanidine hydrochloride, in the presence of tripotassium phosphate [38], catalytic copper(I) iodide [39], in DMSO (solvent/ligand) [40] at 110 °C, furnished an original benzothiopyrano[4,3,2-de]quinazoline. Due to the widespread biological properties of quinazolines, biological studies were performed on the latter, revealing a broad spectrum of activity on the microbial growth of strains of bacteria (not shown). Moreover, the bioactivity of this tetracycle was evaluated against serine/threonine protein kinases, and a promising ability to inhibit PIM kinases (involved in signaling pathways fundamental to cancer development and progression) was revealed by dose-dependent effect [37] (Scheme 9).
The ability of ZnCl2∙TMEDA and LiTMP to act in tandem and thus promote a deprotometalation reaction largely depends on the acidity of the aromatic substrate. While LiTMP can deprotonate the (hetero)aromatic compound before being quenched with ZnCl2∙TMEDA in the example above, things are different with less activated substrates such as anisole [41] (Scheme 10a). However, if Zn(TMP)2 (prepared from two equivalents of LiTMP and ZnCl2∙TMEDA) is used instead of ZnCl2∙TMEDA then similar behavior can be restored [28,41] (Scheme 10b).
This variant has been applied to the functionalization of bare diazines, and in particular of pyrimidine, which is especially prone to nucleophilic attacks [42]. While the use of LiTMP at low temperature has mainly led to the formation of 4,4′-bipyrimidine from this substrate, the 4-lithiated pyrimidine could be trapped in situ by transmetalation to provide, after iodolysis, the expected product 12 in 57% yield [43]. The presence of substituents on the diazine generally favors the reaction, as observed from 2-(methylthio)pyrimidine (product 13) and 2,4-dimethoxy-5-(2,5-dimethoxyphenyl)pyrimidine (product 14; Scheme 11).
Iodopyrimidines are also precursors of heterocycles of potential interest. As an example, the iodide 13 was easily converted to a triarylmethanol, by iodine/lithium exchange in the presence of a ketone [44,45,46] to intercept the lithiated intermediate. Cyclization of this tertiary alcohol finally led to an analog of variolin B [47] (Scheme 12).
Aromatic iodides are also substrates of choice for performing Suzuki–Miyaura cross-coupling reactions [48,49]. As shown in Scheme 13, there is no need to isolate the iodide 14, as it could be easily transformed by an in situ reaction with 2-chlorophenylboronic acid under reported conditions [50] to afford a precursor of diazatriphenylene. Intramolecular C-H arylation [51,52,53] conditions were finally found to reach this tetracycle [54].
While the variant LiTMP-Zn(TMP)2 is able to deprotonate less activated substrates, it is also able to dideprotonate substrates that benefit from two activated positions. As a consequence, diiodides can be formed, as exemplified below, from 2,6-difluoropyridine. In this case using LiTMP (0.5 equiv) and Zn(TMP)2 (0.5 equiv) led to the 3-iodinated 15 (66% yield), while simply increasing these amounts to LiTMP (1 equiv) and Zn(TMP)2 (1 equiv) in the reaction furnished the 3,5-diiodinated 16 in 85% yield [55] (Scheme 14).

3. Aromatic Iodides in Copper-Mediated N-Arylation of Anilines

In the last years, we have been interested in the copper-mediated N-arylation of anilines, which represents a way to reach new scaffolds from the various aromatic iodides we could prepare. Among the halogenated aromatics used as partners in such N-arylation of anilines, thiophenes are poorly represented. When treated with 3-bromothiophene in the presence of N-ethylmorpholine and copper(II) bromide (dimethylformamide, reflux, 2 h), it has been shown that potassium anthranilate was only N-arylated in a moderate 32% yield [56]. A better result was observed by reacting aniline with 3-bromothiophene in water containing potassium hydroxide, tetrabutylammonium bromide, and catalytic chitosan and copper(I) oxide (80% monoarylation yield after 12 h at 70 °C) [57]. 2-Bromobenzothiophene appears to be even less reactive because its cross-coupling with aniline in N,N-dimethylethanolamine containing potassium phosphate and catalytic copper/copper(I) iodide at 85 °C for two days failed [58].
In view of the absence of results relating to the N-arylations of anilines with iodothiophenes, and inspired by the conditions reported by Hellwinkel and Ittemann in the benzene series [59], we selected ethyl anthranilate as the coupling partner. While using 2-iodothiophene only gave the expected product in 52% yield under our optimized conditions (1 equiv activated copper and 2 equiv potassium carbonate in dibutyl ether at 140 °C for 24 h), 3-iodothiophene proved much more reactive, giving the product in 92% yield. Similarly, using 2- and 3-iodobenzothiophene led to the N-arylated products in 57% and 96% yield, respectively (Scheme 15). This trend was attributed to less electron-rich 3-thienyl or benzothienyl groups (facilitating reductive elimination) when compared with 2-thienyls or benzothienyls [60].
Provided that 3-iodothiophene is selected as reaction partner and not the 2-iodinated isomer, both methyl 2-amino-3-thiophenecarboxylate and methyl 3-amino-2-thiophenecarboxylate could be N,N-diarylated in yields similar to those recorded when using iodobenzene (Scheme 16, left). Pleasingly, these aminothiophenes can also be involved in two successive N-arylation reactions with different aromatic or heteroaromatic iodides, affording various triarylamines in moderate to excellent yields (Scheme 16, right) [61].
If the ester function of ethyl anthranilate is replaced by an aldehyde or a ketone, the N-arylation reactions can be followed by ring formations toward fused tricyclic products. If the cyclization, under acidic conditions, is performed after two N-arylation steps, acridones can be reached (the one depicted in Scheme 17a occurred selectively with the phenyl group). On the contrary, if it is carried out after a single N-arylation, acridines are rather obtained as illustrated in Scheme 17b, leading to a molecule endowed with a significant antiproliferative activity against melanoma cells [62].
Interestingly, double N-arylation reactions can also be achieved by using a diiodide as coupling partner. Thus, reaction of 2-aminobenzaldehyde with 1,4-diiodobenzene under the above conditions led to the expected N,N’-disubstituted 1,4-phenylenediamine which, upon acidic treatment, cyclized to afford a diaza-pentacycle in high yield. However, when 1,3-diiodobenzene is used instead, the intermediate N,N’-disubstituted 1,3-phenylenediamine is isolated in a low 12% yield due to its easy cyclization under the coupling conditions (Scheme 18) [62].
To rationalize the regioselectivity of these cyclizations, which are aromatic electrophilic substitutions, we calculated the amplitudes of the HOMO coefficients [3,4] of the N,N’-disubstituted 1,3-phenylenediamine intermediate A and the putative intermediates B and C. Pleasingly, the experimental regioselectivities matched those predicted, with all cyclizations occurring at the carbon site with the highest coefficient (Scheme 19) [63].
Larger aza-aromatic polycycles have been similarly obtained using 2-iodotriphenylene as a coupling partner for the N-arylation of 2-aminobenzaldehyde or 2-aminophenones. The amplitudes of the HOMO coefficients showed a cyclization slightly in favor of the most hindered position. However, this has only been verified experimentally from the aldehyde and not from the ketones, probably for steric reasons. The aza-hexacycles thus obtained showed a significant fluorescence (Scheme 20) [63].
In order to prepare a helicene-like structure with a substituent opposite the nitrogen, we coupled ethyl anthranilate with 2-iodotriphenylene. The ester function was next hydrolyzed, and the corresponding 4-chloroacridine skeleton was built in the presence of phosphorus oxychloride. Finally, the chloro group was replaced to afford the expected target (Scheme 21) [63].
As before, we prepared original acridones from 2-aminobenzaldehyde by introducing aryl groups, either different or similar, before cyclization under conditions using ytterbium(III) triflate reported by Yang et al. [64]. As before, our regioselectivity predictions applied when steric hindrance was not predominant (Scheme 22) [63].
As already observed by coupling 2-aminobenzaldehyde with 1,3-diiodobenzene (Scheme 18), using 2-iodobenzothiophene or 2-iodobenzofuran as coupling partner directly leads to polycycles; indeed, cyclization of the N-arylated product directly takes place under the coupling conditions. As illustrated in Scheme 23, this was employed to access tetracycles of biological interest such as benzothieno[2,3-b]quinolines and benzofuro[2,3-b][1,8]naphthyridines [60,65].
Interestingly, this N-arylation-cyclization sequence was applied to access helicene-like benzo(thio)pyrano[4,3,2-de]benzothieno[2,3-b]quinolines which are heterocycles of biological interest. In this context, the hexacycle depicted in Scheme 24 was prepared in two steps from the 1-iodothioxanthone (11b). This iodide was first converted to the corresponding aniline which was engaged in the N-arylation reaction with 2-iodobenzothiophene. The formed hexacycle proved to be a promising inhibitor of PIM protein kinases which are related to cancer development [66].

4. Conclusions

The many examples presented throughout this mini-review demonstrate the interest of direct iodination reactions and deprotometallation–trapping sequences to access iodinated aromatics. The latter are relevant substrates for many reactions, and in particular for copper-catalyzed couplings, which make it possible to develop original heterocyclic structures.

Author Contributions

Writing—original draft preparation, F.M.; writing—review and editing, W.E. and F.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We would like to thank all the contributors to the presented studies.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Begunov, R.S.; Sokolov, A.A.; Belova, V.O.; Solov’ev, M.E. Quantum chemical study of regioselectivity of reactions of substituted pyrido[1,2-a]benzimidazoles with electrophiles. Russ. Chem. Bull. 2016, 65, 644–647. [Google Scholar] [CrossRef]
  2. Fukui, K.; Yonezawa, T.; Nagata, C.; Shingu, H. Molecular-orbital theory of orientation in aromatic, heteroaromatic, and other conjugated molecules. J. Chem. Phys. 1954, 22, 1433–1442. [Google Scholar] [CrossRef] [Green Version]
  3. Carissan, Y.; Hagebaum-Reignier, D.; Goudard, N.; Humbel, S. Hückel-Lewis projection method: A "weights watcher" for mesomeric structures. J. Phys. Chem. A 2008, 112, 13256–13262. [Google Scholar] [CrossRef]
  4. Goudard, N.; Carissan, Y.; Hagebaum-Reignier, D.; Humbel, S. HuLiS 3.3.4: Simple HÜckel and LewIS Embedded in the Hückel Theory. Available online: https://ism2.univ-amu.fr/hulis (accessed on 1 January 2008).
  5. Ameur Messaoud, M.Y.; Bentabed-Ababsa, G.; Fajloun, Z.; Hamze, M.; Halauko, Y.S.; Ivashkevich, O.A.; Matulis, V.E.; Roisnel, T.; Dorcet, V.; Mongin, F. Deprotometalation-iodolysis and direct iodination of 1-arylated 7-azaindoles: Reactivity studies and molecule properties. Molecules 2021, 26, 6314. [Google Scholar] [CrossRef]
  6. Lassagne, F.; Chevallier, F.; Mongin, F. Saccharin as an organocatalyst for quinoxalines and pyrido[2,3-b]pyrazines syntheses. Synth. Commun. 2014, 44, 141–149. [Google Scholar] [CrossRef]
  7. Saini, K.M.; Saunthwal, R.K.; Kumar, S.; Verma, A.K. On water: Metal-free synthesis of highly functionalized benzothiazolylidene from ortho-haloanilines. J. Org. Chem. 2019, 84, 2689–2698. [Google Scholar] [CrossRef]
  8. Huang, Y.; Yan, D.; Wang, X.; Zhou, P.; Wu, W.; Jiang, H. Controllable assembly of the benzothiazole framework using a C≡C bond as a one-carbon synthon. Chem. Commun. 2018, 54, 1742–1745. [Google Scholar] [CrossRef]
  9. Lassagne, F.; Sims, J.M.; Erb, W.; Mongin, O.; Richy, N.; El Osmani, N.; Fajloun, Z.; Picot, L.; Thiery, V.; Robert, T.; et al. Thiazolo[5,4-f]quinoxalines, oxazolo[5,4-f]quinoxalines and pyrazino[b,e]isatins: Synthesis from 6-aminoquinoxalines and properties. Eur. J. Org. Chem. 2021, 2021, 2756–2763. [Google Scholar] [CrossRef]
  10. Demmer, C.S.; Bunch, L. Benzoxazoles and oxazolopyridines in medicinal chemistry studies. Eur. J. Med. Chem. 2015, 97, 778–785. [Google Scholar] [CrossRef]
  11. Viirre, R.D.; Evindar, G.; Batey, R.A. Copper-catalyzed domino annulation approaches to the synthesis of benzoxazoles under microwave-accelerated and conventional thermal conditions. J. Org. Chem. 2008, 73, 3452–3459. [Google Scholar] [CrossRef]
  12. Lassagne, F.; Duguépéroux, C.; Roca, C.; Perez, C.; Martinez, A.; Baratte, B.; Robert, T.; Ruchaud, S.; Bach, S.; Erb, W.; et al. From simple quinoxalines to potent oxazolo[5,4-f]quinoxaline inhibitors of glycogen-synthase kinase 3 (GSK3). Org. Biomol. Chem. 2020, 18, 154–162. [Google Scholar] [CrossRef] [PubMed]
  13. Sonogashira, K.; Tohda, Y.; Hagihara, N. A Convenient synthesis of acetylenes: Catalytic substitutions of acetylenic hydrogen with bromo alkenes, iodo arenes, and bromopyridines. Tetrahedron Lett. 1975, 16, 4467–4470. [Google Scholar] [CrossRef]
  14. Aburano, D.; Yoshida, T.; Miyakoshi, N.; Mukai, C. Synthesis of hexahydropyrrolo[2,3-b]indole alkaloids based on the aza-pauson-khand-type reaction of alkynecarbodiimides. J. Org. Chem. 2007, 72, 6878–6884. [Google Scholar] [CrossRef] [PubMed]
  15. Gschwend, H.W.; Rodriguez, H.R. Heteroatom-facilitated lithiations. Org. React. 1979, 26, 1–360. [Google Scholar]
  16. Gant, T.G.; Meyers, A.I. The chemistry of 2-oxazolines (1985-present). Tetrahedron 1994, 50, 2297–2360. [Google Scholar] [CrossRef]
  17. Schlosser, M. Organometallics in Synthesis, 2nd ed.; Schlosser, M., Ed.; Wiley: New York, NY, USA, 2002; Chapter I. [Google Scholar]
  18. Hartung, C.G.; Snieckus, V. The directed ortho metalation reaction—A point of departure for new synthetic aromatic chemistry. In Modern Arene Chemistry; Astruc, D., Ed.; Wiley: New York, NY, USA, 2002; Chapter 10; pp. 330–367. [Google Scholar]
  19. Clayden, J. Directed metalation of aromatic compounds. Chem. Organolithium Compd. 2004, 1, 495–646. [Google Scholar] [CrossRef]
  20. Tilly, D.; Magolan, J.; Mortier, J. Directed remote aromatic metalations: Mechanisms and driving forces. Chem. Eur. J. 2012, 18, 3804–3820. [Google Scholar] [CrossRef]
  21. Mulvey, R.E.; Mongin, F.; Uchiyama, M.; Kondo, Y. Deprotonative metalation using ate compounds: Synergy, synthesis, and structure building. Angew. Chem. Int. Ed. 2007, 46, 3802–3824. [Google Scholar] [CrossRef]
  22. Mulvey, R.E. Avant-garde metalating agents: Structural basis of alkali-metal-mediated metalation. Acc. Chem. Res. 2009, 42, 743–755. [Google Scholar] [CrossRef]
  23. Haag, B.; Mosrin, M.; Ila, H.; Malakhov, V.; Knochel, P. Regio- and chemoselective metalation of arenes and heteroarenes using hindered metal amide bases. Angew. Chem. Int. Ed. 2011, 50, 9794–9824. [Google Scholar] [CrossRef]
  24. Mongin, F.; Harrison-Marchand, A. Mixed AggregAte (MAA): A single concept for all dipolar organometallic aggregates. 2. Syntheses and reactivities of homo/heteroMAAs. Chem. Rev. 2013, 113, 7563–7727. [Google Scholar] [CrossRef] [PubMed]
  25. Mulvey, R.E. An alternative picture of alkali-metal-mediated metallation: Cleave and capture chemistry. Dalton Trans. 2013, 42, 6676–6693. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Harford, P.J.; Peel, A.J.; Chevallier, F.; Takita, R.; Mongin, F.; Uchiyama, M.; Wheatley, A.E.H. New avenues in the directed deprotometallation of aromatics: Recent advances in directed cupration. Dalton Trans. 2014, 43, 14181–14203. [Google Scholar] [CrossRef] [Green Version]
  27. Lysén, M.; Hansen, H.M.; Begtrup, M.; Kristensen, J.L. Synthesis of substituted 2-cyanoarylboronic esters. J. Org. Chem. 2006, 71, 2518–2520. [Google Scholar] [CrossRef]
  28. Mokhtari Brikci-Nigassa, N.; Bentabed-Ababsa, G.; Erb, W.; Mongin, F. In situ ‘trans-metal trapping’: An efficient way to extend the scope of aromatic deprotometalation. Synthesis 2018, 50, 3615–3633. [Google Scholar]
  29. Lassagne, F.; Langlais, T.; Caytan, E.; Limanton, E.; Paquin, L.; Boullard, M.; Courtel, C.; Curbet, I.; Gedeon, C.; Lebreton, J.; et al. From quinoxaline, pyrido[2,3-b]pyrazine and pyrido[3,4-b]pyrazine to pyrazino-fused carbazoles and carbolines. Molecules 2018, 23, 2961. [Google Scholar] [CrossRef] [Green Version]
  30. Van Baelen, G.; Meyers, C.; Lemière, G.L.F.; Hostyn, S.; Dommisse, R.; Maes, L.; Augustyns, K.; Haemers, A.; Pieters, L.; Maes, B.U.W. Synthesis of 6-methyl-6H-indolo[3,2-c]isoquinoline and 6-methyl-6H-indolo[2,3-c]isoquinoline: Two new unnatural isoquinoline isomers of the cryptolepine series. Tetrahedron 2008, 64, 11802–11809. [Google Scholar] [CrossRef]
  31. Van Baelen, G.; Hostyn, S.; Dhooghe, L.; Tapolcsányi, P.; Mátyus, P.; Lemière, G.; Dommisse, R.; Kaiser, M.; Brun, R.; Cos, P.; et al. Structure-activity relationship of antiparasitic and cytotoxic indoloquinoline alkaloids, and their tricyclic and bicyclic analogues. Bioorg. Med. Chem. 2009, 17, 7209–7217. [Google Scholar] [CrossRef]
  32. Queguiner, G.; Marsais, F.; Snieckus, V.; Epsztajn, J. Directed metalation of pi-deficient azaaromatics: Strategies of functionalization of pyridines, quinolines, and diazines. Adv. Heterocycl. Chem. 1991, 52, 187–304. [Google Scholar]
  33. Turck, A.; Plé, N.; Mongin, F.; Queguiner, G. Advances in the directed metallation of azines and diazines (pyridines, pyrimidines, pyrazines, pyridazines, quinolines, benzodiazines and carbolines). Part 2: Metallation of pyrimidines, pyrazines, pyridazines and benzodiazines. Tetrahedron 2001, 57, 4489–4505. [Google Scholar] [CrossRef]
  34. Chevallier, F.; Mongin, F. Functionalization of diazines and benzo derivatives through deprotonated intermediates. Chem. Soc. Rev. 2008, 37, 595–609. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Bisballe, N.; Hedidi, M.; Demmer, C.S.; Chevallier, F.; Roisnel, T.; Dorcet, V.; Halauko, Y.S.; Ivashkevich, O.A.; Matulis, V.E.; Bentabed-Ababsa, G.; et al. Functionalization of oxazolo[4,5-b]pyrazines by deprotometallation. Eur. J. Org. Chem. 2018, 2018, 3904–3913. [Google Scholar] [CrossRef]
  36. Hedidi, M.; Erb, W.; Lassagne, F.; Halauko, Y.S.; Ivashkevich, O.A.; Matulis, V.E.; Roisnel, T.; Bentabed-Ababsa, G.; Mongin, F. Functionalization of pyridyl ketones using deprotolithiation-in situ zincation. RSC Adv. 2016, 6, 63185–63189. [Google Scholar] [CrossRef]
  37. Hedidi, M.; Maillard, J.; Erb, W.; Lassagne, F.; Halauko, Y.S.; Ivashkevich, O.A.; Matulis, V.E.; Roisnel, T.; Dorcet, V.; Hamzé, M.; et al. Fused systems based on 2-aminopyrimidines: Synthesis combining deprotolithiation-in situ zincation with N-arylation reactions and biological properties. Eur. J. Org. Chem. 2017, 2017, 5903–5915. [Google Scholar] [CrossRef]
  38. Antilla, J.C.; Baskin, J.M.; Barder, T.E.; Buchwald, S.L. Copper-diamine-catalyzed n-arylation of pyrroles, pyrazoles, indazoles, imidazoles, and triazoles. J. Org. Chem. 2004, 69, 5578–5587. [Google Scholar] [CrossRef]
  39. Gao, L.; Song, Y.; Zhang, X.; Guo, S.; Fan, X. Copper-catalyzed tandem reactions of 2-bromobenzaldehydes/ketones with aminopyrazoles toward the synthesis of pyrazolo[1,5-a]quinazolines. Tetrahedron Lett. 2014, 55, 4997–5002. [Google Scholar] [CrossRef]
  40. Teo, Y.-C.; Yong, F.-F.; Sim, S. Ligand-free cu2o-catalyzed cross coupling of nitrogen heterocycles with iodopyridines. Tetrahedron 2013, 69, 7279–7284. [Google Scholar] [CrossRef]
  41. Akimoto, G.; Otsuka, M.; Takita, R.; Uchiyama, M.; Hedidi, M.; Bentabed-Ababsa, G.; Lassagne, F.; Erb, W.; Mongin, F. Deprotonative metalation of methoxy-substituted arenes using lithium 2,2,6,6-tetramethylpiperidide: Experimental and computational study. J. Org. Chem. 2018, 83, 13498–13506. [Google Scholar] [CrossRef]
  42. Plé, N.; Turck, A.; Couture, K.; Quéguiner, G. Diazines 13: Metalation without ortho-directing group—Functionalization of diazines via direct metalation. J. Org. Chem. 1995, 60, 3781–3786. [Google Scholar] [CrossRef]
  43. Seggio, A.; Chevallier, F.; Vaultier, M.; Mongin, F. Lithium-mediated zincation of pyrazine, pyridazine, pyrimidine, and quinoxaline. J. Org. Chem. 2007, 72, 6602–6605. [Google Scholar] [CrossRef]
  44. Anderson, R.J.; Morris, J.C. Total synthesis of variolin B. Tetrahedron Lett. 2001, 42, 8697–8699. [Google Scholar] [CrossRef] [Green Version]
  45. Anderson, R.J.; Hill, J.B.; Morris, J.C. Concise total syntheses of variolin B and deoxyvariolin B. J. Org. Chem. 2005, 70, 6204–6212. [Google Scholar] [CrossRef] [PubMed]
  46. Anderson, R.J.; Morris, J.C. Studies toward the total synthesis of the variolins: Rapid entry to the core structure. Tetrahedron Lett. 2001, 42, 311–313. [Google Scholar] [CrossRef]
  47. Marquise, N.; Nguyen, T.T.; Chevallier, F.; Picot, L.; Thiery, V.; Lozach, O.; Bach, S.; Ruchaud, S.; Mongin, F. Azine and diazine functionalization using 2,2,6,6-tetramethylpiperidino-based lithium-metal combinations: Application to the synthesis of 5,9-disubstituted pyrido[3′,2′:4,5]pyrrolo[1,2-c]pyrimidines. Synlett 2015, 26, 2811–2816. [Google Scholar] [CrossRef]
  48. Miyaura, N.; Suzuki, A. Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chem. Rev. 1995, 95, 2457–2483. [Google Scholar] [CrossRef] [Green Version]
  49. Kotha, S.; Lahiri, K.; Kashinath, D. Recent applications of the Suzuki-Miyaura cross-coupling reaction in organic synthesis. Tetrahedron 2002, 58, 9633–9695. [Google Scholar] [CrossRef] [Green Version]
  50. Sreeshailam, A.; Dayaker, G.; Ramana, D.V.; Chevallier, F.; Roisnel, T.; Komagawa, S.; Takita, R.; Uchiyama, M.; Radha Krishna, P.; Mongin, F. Synthesis of both enantiomers of ferrocene[1,2-c]1H-quinolin-2-one by diastereoselective deproto-zincation of sugar-derived ferrocene esters. RSC Adv. 2012, 2, 7030–7032. [Google Scholar] [CrossRef] [Green Version]
  51. Alberico, D.; Scott, M.E.; Lautens, M. Aryl-aryl bond formation by transition-metal-catalyzed direct arylation. Chem. Rev. 2007, 107, 174–238. [Google Scholar] [CrossRef]
  52. Chen, X.; Engle, K.M.; Wang, D.-H.; Yu, J.-Q. Palladium(II)-catalyzed C-H activation/C-C cross-coupling reactions: Versatility and practicality. Angew. Chem. Int. Ed. 2009, 48, 5094–5115. [Google Scholar] [CrossRef]
  53. Ackermann, L.; Vicente, R.; Kapdi, A.R. Transition metal-catalyzed direct arylation of (hetero)arenes by C-H bond cleavage. Angew. Chem. Int. Ed. 2009, 48, 9792–9826. [Google Scholar] [CrossRef]
  54. Kadiyala, R.R.; Tilly, D.; Nagaradja, E.; Roisnel, T.; Matulis, V.E.; Ivashkevich, O.A.; Halauko, Y.S.; Chevallier, F.; Gros, P.C.; Mongin, F. Computed CH acidity of biaryl compounds and their deprotonative metalation by using a mixed lithium/zinc-TMP base. Chem. Eur. J. 2013, 19, 7944–7960. [Google Scholar] [CrossRef]
  55. Hedidi, M.; Bentabed-Ababsa, G.; Derdour, A.; Halauko, Y.S.; Ivashkevich, O.A.; Matulis, V.E.; Chevallier, F.; Roisnel, T.; Dorcet, V.; Mongin, F. Deprotometalation of substituted pyridines and regioselectivity-computed CH acidity relationships. Tetrahedron 2016, 72, 2196–2205. [Google Scholar] [CrossRef]
  56. Elslager, E.F.; Haley, N.F.; McLean, J.R.; Potoczak, D.; Veloso, H.; Wheelock, R.H. Inhibitors of platelet aggregation. 3. {[(dialkylamino)alkyl]thio} heterocyclic compounds. J. Med. Chem. 1972, 15, 61–65. [Google Scholar] [CrossRef]
  57. Yang, B.; Mao, Z.; Zhu, X.; Wan, Y. Functionalised chitosan as a green, recyclable, supported catalyst for the copper-catalysed ullmann C-N coupling reaction in water. Catal. Commun. 2015, 60, 92–95. [Google Scholar] [CrossRef]
  58. Lu, Z.; Twieg, R.J. A mild and practical copper-catalyzed amination of halothiophenes. Tetrahedron 2005, 61, 903–918. [Google Scholar] [CrossRef]
  59. Hellwinkel, D.; Ittemann, P. 12-Organyldibenz[b,g]azocine-5,7-diones. Chem. Ber. 1986, 119, 3165–3197. [Google Scholar] [CrossRef]
  60. Bouarfa, S.; Bentabed-Ababsa, G.; Erb, W.; Picot, L.; Thiery, V.; Roisnel, T.; Dorcet, V.; Mongin, F. Iodothiophenes and related compounds as coupling partners in copper-mediated n-arylation of anilines. Synthesis 2021, 53, 1271–1284. [Google Scholar]
  61. Bouarfa, S.; Grassl, S.; Ivanova, M.; Langlais, T.; Bentabed-Ababsa, G.; Lassagne, F.; Erb, W.; Roisnel, T.; Dorcet, V.; Knochel, P.; et al. Copper- and cobalt-catalyzed syntheses of thiophene-based tertiary amines. Eur. J. Org. Chem. 2019, 2019, 3244–3258. [Google Scholar] [CrossRef] [Green Version]
  62. Zeghada, S.; Bentabed-Ababsa, G.; Mongin, O.; Erb, W.; Picot, L.; Thiery, V.; Roisnel, T.; Dorcet, V.; Mongin, F. 2-Aminobenzaldehyde, a common precursor to acridines and acridones endowed with bioactivities. Tetrahedron 2020, 76, 131435. [Google Scholar] [CrossRef]
  63. Bouarfa, S.; Jehan, P.; Erb, W.; Mongin, O.; Poree, F.-H.; Roisnel, T.; Bentabed-Ababsa, G.; Le Yondre, N.; Mongin, F. Aza-aromatic polycycles based on triphenylene and acridine or acridone: Synthesis and properties. New J. Chem. 2021, 45, 14414–14424. [Google Scholar] [CrossRef]
  64. Li, X.-A.; Wang, H.-L.; Yang, S.-D. Sc(OTf)3-catalyzed dehydrogenative cyclization for synthesis of N-methylacridones. Org. Lett. 2013, 15, 1794–1797. [Google Scholar] [CrossRef] [PubMed]
  65. Mokhtari Brikci-Nigassa, N.; Bentabed-Ababsa, G.; Erb, W.; Chevallier, F.; Picot, L.; Vitek, L.; Fleury, A.; Thiéry, V.; Souab, M.; Robert, T.; et al. 2-Aminophenones, a common precursor to N-aryl isatins and acridines endowed with bioactivities. Tetrahedron 2018, 74, 1785–1801. [Google Scholar] [CrossRef] [Green Version]
  66. Mokhtari Brikci-Nigassa, N.; Nauton, L.; Moreau, P.; Mongin, O.; Duval, R.E.; Picot, L.; Thiery, V.; Souab, M.; Baratte, B.; Ruchaud, S.; et al. Functionalization of 9-thioxanthone at the 1-position: From arylamino derivatives to [1]benzo(thio)pyrano[4,3,2-de]benzothieno[2,3-b]quinolines of biological interest. Bioorg. Chem. 2020, 94, 103347. [Google Scholar] [CrossRef] [PubMed]
Chemproc 12 00020 g001 550
Figure 1. (Left) HOMO coefficients (obtained by using the HuLiS calculator [4]) and calculated C charges (in brackets) for 1-(3,5-dimethylphenyl)-7-azaindole and 1-(2-thienyl)-7-azaindole. (Right) Halogenated products 1 and 2 obtained after treatment with iodine.
Figure 1. (Left) HOMO coefficients (obtained by using the HuLiS calculator [4]) and calculated C charges (in brackets) for 1-(3,5-dimethylphenyl)-7-azaindole and 1-(2-thienyl)-7-azaindole. (Right) Halogenated products 1 and 2 obtained after treatment with iodine.
Chemproc 12 00020 g001
Chemproc 12 00020 g002 550
Figure 2. HOMO coefficients (obtained by using the HuLiS calculator [4]) for substituted 6-aminoquinoxalines and products 3–5 resulting from their iodination.
Figure 2. HOMO coefficients (obtained by using the HuLiS calculator [4]) for substituted 6-aminoquinoxalines and products 3–5 resulting from their iodination.
Chemproc 12 00020 g002
Chemproc 12 00020 sch001 550
Scheme 1. Conversion of 3 into thiazolo[5,4-f]quinoxalines.
Scheme 1. Conversion of 3 into thiazolo[5,4-f]quinoxalines.
Chemproc 12 00020 sch001
Chemproc 12 00020 sch002 550
Scheme 2. Conversion of 3 into oxazolo[5,4-f]quinoxalines and activity on GSK3 kinases.
Scheme 2. Conversion of 3 into oxazolo[5,4-f]quinoxalines and activity on GSK3 kinases.
Chemproc 12 00020 sch002
Chemproc 12 00020 sch003 550
Scheme 3. Conversion of 4 and 5 into pyrazino[b,e]isatins.
Scheme 3. Conversion of 4 and 5 into pyrazino[b,e]isatins.
Chemproc 12 00020 sch003
Chemproc 12 00020 sch004 550
Scheme 4. Conversion of 2,3-diphenylquinoxaline into the 5-iodinated derivative 6.
Scheme 4. Conversion of 2,3-diphenylquinoxaline into the 5-iodinated derivative 6.
Chemproc 12 00020 sch004
Chemproc 12 00020 sch005 550
Scheme 5. Conversion of pyrido[2,3-b]pyrazine into the 5-iodinated derivative 7 and application to the synthesis of a pyrazino-fused azacarbazole.
Scheme 5. Conversion of pyrido[2,3-b]pyrazine into the 5-iodinated derivative 7 and application to the synthesis of a pyrazino-fused azacarbazole.
Chemproc 12 00020 sch005
Chemproc 12 00020 sch006 550
Scheme 6. Conversion of 2-phenyloxazolo[4,5-b]pyrazine into monoiodinated derivatives 8 and 8′, or diiodinated derivative 9, and application to the synthesis of a pyrazino-fused azacarbazole.
Scheme 6. Conversion of 2-phenyloxazolo[4,5-b]pyrazine into monoiodinated derivatives 8 and 8′, or diiodinated derivative 9, and application to the synthesis of a pyrazino-fused azacarbazole.
Chemproc 12 00020 sch006
Chemproc 12 00020 sch007 550
Scheme 7. Functionalization of 3-benzoylpyridines toward the iodides 10 by deprotometalation with in situ trapping followed by iodolysis.
Scheme 7. Functionalization of 3-benzoylpyridines toward the iodides 10 by deprotometalation with in situ trapping followed by iodolysis.
Chemproc 12 00020 sch007
Chemproc 12 00020 sch008 550
Scheme 8. Functionalization of various (hetero)aromatic ketones toward the monoiodides 11 and the by-products 11′. (a) Efficient and (b) less efficient reactions. 1 Reaction carried out at −30 °C.
Scheme 8. Functionalization of various (hetero)aromatic ketones toward the monoiodides 11 and the by-products 11′. (a) Efficient and (b) less efficient reactions. 1 Reaction carried out at −30 °C.
Chemproc 12 00020 sch008
Chemproc 12 00020 sch009 550
Scheme 9. Conversion of the aromatic iodide 11b into a benzothiopyrano[4,3,2-de]quinazoline promising as PIM kinase inhibitor.
Scheme 9. Conversion of the aromatic iodide 11b into a benzothiopyrano[4,3,2-de]quinazoline promising as PIM kinase inhibitor.
Chemproc 12 00020 sch009
Chemproc 12 00020 sch010 550
Scheme 10. (a) Unsuccessful use of LiTMP-ZnCl2∙TMEDA for the deprotometalation with in situ trapping–iodolysis of unactivated aromatic substrates. (b) Successful use of LiTMP-Zn(TMP)2 for the deprotometalation with in situ trapping–iodolysis of unactivated aromatic substrates.
Scheme 10. (a) Unsuccessful use of LiTMP-ZnCl2∙TMEDA for the deprotometalation with in situ trapping–iodolysis of unactivated aromatic substrates. (b) Successful use of LiTMP-Zn(TMP)2 for the deprotometalation with in situ trapping–iodolysis of unactivated aromatic substrates.
Chemproc 12 00020 sch010
Chemproc 12 00020 sch011 550
Scheme 11. Functionalization of pyrimidine, 2-(methylthio)pyrimidine (left) and 2,4-dimethoxy-5-(2,5-dimethoxyphenyl)pyrimidine (right) toward the iodides 12–14, respectively, by deprotometalation with in situ trapping followed by iodolysis.
Scheme 11. Functionalization of pyrimidine, 2-(methylthio)pyrimidine (left) and 2,4-dimethoxy-5-(2,5-dimethoxyphenyl)pyrimidine (right) toward the iodides 12–14, respectively, by deprotometalation with in situ trapping followed by iodolysis.
Chemproc 12 00020 sch011
Chemproc 12 00020 sch012 550
Scheme 12. Conversion of the iodide 13 into an analog of variolin B.
Scheme 12. Conversion of the iodide 13 into an analog of variolin B.
Chemproc 12 00020 sch012
Chemproc 12 00020 sch013 550
Scheme 13. Formation of the iodide 14 and in situ conversion to a diazatriphenylene.
Scheme 13. Formation of the iodide 14 and in situ conversion to a diazatriphenylene.
Chemproc 12 00020 sch013
Chemproc 12 00020 sch014 550
Scheme 14. Functionalization of 2,6-difluoropyridine, either at C3 (left) or at C3 and C5 (right) toward the iodides 15 and 16, respectively, by deprotometalation with in situ trapping followed by iodolysis.
Scheme 14. Functionalization of 2,6-difluoropyridine, either at C3 (left) or at C3 and C5 (right) toward the iodides 15 and 16, respectively, by deprotometalation with in situ trapping followed by iodolysis.
Chemproc 12 00020 sch014
Chemproc 12 00020 sch015 550
Scheme 15. N-Arylation of ethyl anthranilate using 2- or 3-iodothiophene, and 2- or 3-iodobenzothiophene.
Scheme 15. N-Arylation of ethyl anthranilate using 2- or 3-iodothiophene, and 2- or 3-iodobenzothiophene.
Chemproc 12 00020 sch015
Chemproc 12 00020 sch016 550
Scheme 16. Single (top) and double (bottom) N-arylation of methyl 2-amino-3-thiophenecarboxylate and methyl 3-amino-2-thiophenecarboxylate toward triarylamines.
Scheme 16. Single (top) and double (bottom) N-arylation of methyl 2-amino-3-thiophenecarboxylate and methyl 3-amino-2-thiophenecarboxylate toward triarylamines.
Chemproc 12 00020 sch016
Chemproc 12 00020 sch017 550
Scheme 17. Access to (a) acridone and (b) acridine scaffolds by double and single N-arylation, respectively, followed by cyclization.
Scheme 17. Access to (a) acridone and (b) acridine scaffolds by double and single N-arylation, respectively, followed by cyclization.
Chemproc 12 00020 sch017
Chemproc 12 00020 sch018 550
Scheme 18. Access to diaza-pentacycles by double N-arylation followed by cyclization.
Scheme 18. Access to diaza-pentacycles by double N-arylation followed by cyclization.
Chemproc 12 00020 sch018
Chemproc 12 00020 sch019 550
Scheme 19. HOMO coefficients (obtained by using the HuLiS calculator [4]) of the N,N’-disubstituted 1,3-phenylenediamine intermediate A and of the putative intermediates B and C.
Scheme 19. HOMO coefficients (obtained by using the HuLiS calculator [4]) of the N,N’-disubstituted 1,3-phenylenediamine intermediate A and of the putative intermediates B and C.
Chemproc 12 00020 sch019
Chemproc 12 00020 sch020 550
Scheme 20. Formation of aza-aromatic hexacycles by coupling 2-aminobenzaldehyde or 2-aminophenones with 2-iodotriphenylene.
Scheme 20. Formation of aza-aromatic hexacycles by coupling 2-aminobenzaldehyde or 2-aminophenones with 2-iodotriphenylene.
Chemproc 12 00020 sch020
Chemproc 12 00020 sch021 550
Scheme 21. Synthesis of a helicene-like aza-aromatic hexacycle.
Scheme 21. Synthesis of a helicene-like aza-aromatic hexacycle.
Chemproc 12 00020 sch021
Chemproc 12 00020 sch022 550
Scheme 22. Synthesis of polycyclic acridones.
Scheme 22. Synthesis of polycyclic acridones.
Chemproc 12 00020 sch022
Chemproc 12 00020 sch023 550
Scheme 23. Synthesis of a benzothieno[2,3-b]quinoline and a benzofuro[2,3-b][1,8]naphthyridine.
Scheme 23. Synthesis of a benzothieno[2,3-b]quinoline and a benzofuro[2,3-b][1,8]naphthyridine.
Chemproc 12 00020 sch023
Chemproc 12 00020 sch024 550
Scheme 24. Synthesis of a benzothiopyrano[4,3,2-de]benzothieno[2,3-b]quinoline.
Scheme 24. Synthesis of a benzothiopyrano[4,3,2-de]benzothieno[2,3-b]quinoline.
Chemproc 12 00020 sch024
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mongin, F.; Erb, W.; Lassagne, F. Aromatic Iodides: Synthesis and Conversion to Heterocycles. Chem. Proc. 2022, 12, 20. https://doi.org/10.3390/ecsoc-26-13641

AMA Style

Mongin F, Erb W, Lassagne F. Aromatic Iodides: Synthesis and Conversion to Heterocycles. Chemistry Proceedings. 2022; 12(1):20. https://doi.org/10.3390/ecsoc-26-13641

Chicago/Turabian Style

Mongin, Florence, William Erb, and Frédéric Lassagne. 2022. "Aromatic Iodides: Synthesis and Conversion to Heterocycles" Chemistry Proceedings 12, no. 1: 20. https://doi.org/10.3390/ecsoc-26-13641

APA Style

Mongin, F., Erb, W., & Lassagne, F. (2022). Aromatic Iodides: Synthesis and Conversion to Heterocycles. Chemistry Proceedings, 12(1), 20. https://doi.org/10.3390/ecsoc-26-13641

Article Metrics

Back to TopTop